GetTopicDetailResponse(id=0ddd2265173, topicName=臨床1期, introduction=臨床1期, content=null, image=null, comments=3, allHits=1019, url=https://h5.medsci.cn/topic?id=22651, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=70625, tagList=[TagDto(tagId=70625, tagName=臨床1期)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2058404, encodeId=cf76205840440, content=<a href='/topic/show?id=0ddd2265173' target=_blank style='color:#2F92EE;'>#臨床1期#</a>, objectTitle=知臨集團(tuán)從加拿大公共衛(wèi)生局獲得啟動(dòng)ALS-4——用于治療金黃色葡萄球菌（包括耐甲氧西林金黃色葡萄球菌（MRSA））感染的小分子藥物——的臨床1期試驗(yàn)許可, objectType=article, longId=205999, objectId=0f8e205999ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f8e205999ca, replyNumber=0, likeNumber=114, createdTime=2021-04-13, rootId=0, userName=xlwang2691, userId=e6ac207, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f8e205999ca, moduleTitle=知臨集團(tuán)從加拿大公共衛(wèi)生局獲得啟動(dòng)ALS-4——用于治療金黃色葡萄球菌（包括耐甲氧西林金黃色葡萄球菌（MRSA））感染的小分子藥物——的臨床1期試驗(yàn)許可, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=0f8e205999ca)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2058403, encodeId=3a5e205840327, content=<a href='/topic/show?id=0ddd2265173' target=_blank style='color:#2F92EE;'>#臨床1期#</a>, objectTitle=無需冷鏈運(yùn)輸?shù)慕Y(jié)核病疫苗將進(jìn)入臨床1期實(shí)驗(yàn), objectType=article, longId=159085, objectId=9f0e159085dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f0e159085dd, replyNumber=0, likeNumber=88, createdTime=2019-10-18, rootId=0, userName=xlwang2691, userId=e6ac207, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f0e159085dd, moduleTitle=無需冷鏈運(yùn)輸?shù)慕Y(jié)核病疫苗將進(jìn)入臨床1期實(shí)驗(yàn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=9f0e159085dd)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2058402, encodeId=44ab2058402a1, content=<a href='/topic/show?id=0ddd2265173' target=_blank style='color:#2F92EE;'>#臨床1期#</a>, objectTitle=J CLIN ONCOL :溶瘤病毒對(duì)抗腦瘤！臨床1期顯示：顯著延長患者生存期, objectType=article, longId=130788, objectId=9841130e8875, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9841130e8875, replyNumber=0, likeNumber=99, createdTime=2018-05-18, rootId=0, userName=xlwang2691, userId=e6ac207, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9841130e8875, moduleTitle=J CLIN ONCOL :溶瘤病毒對(duì)抗腦瘤！臨床1期顯示：顯著延長患者生存期, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=9841130e8875)], followStatus=false, userIsMember=true, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
